Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2447)	3/31/2000 7:40:00 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

<However, claiming that a nasal gel matrix, whether it contains zinc or not, has the ability to inhibit a complex immune response is simply insane.> Have you heard of NasalChrom? You mean to tell me that you expect people to believe that putting the right ingredient in the gel matrix couldn't reduce allergy symptoms? Ya, Hank. I believe you. LMAO Gel Tech will more than likely use their gel matrix for other products as well. Retailers must be pleased with sales of Zicam Cold Remedy or they wouldn't be ordering Zicam Allergy Relief. Why would they fully stock the channel if they didn't have confidence in the brand or if Zicam Cold Remedy wasn't selling well? Regarding the disclaimer that you posted, it says "we have obtained such scientific data for all of our products" It also says "There can be no assurance that the scientific data we have obtained in support of such claims will be deemed acceptable to the FDA or FTC." Of course their lawyers are going to make them say this. All companies have weasel words like this in their financial statements.

To: Hank who wrote (2447)	3/31/2000 9:51:00 AM
From: Mike M	Read Replies (2) \| Respond to of 5582

Hank, you don't recognize yourself but you are the pathetic one. You squawk like a stuck hog who can't have his way. You take a product that hundreds of thousands if not millions of people have now used and many sing its praises and because you don't understand it you single handedly have undertaken to besmirch this company. You are pathetic. There are plenty of things in this world you don't understand. Take them on if you want with your quixotic ramblings. Your silly prognostications are fine for theatre but carry no weight in the business world. If you really want to be scientific and objective about this continue to wait until such time as we can be assured that no one intends to publish the recent clinicals. Your harang is not only childish but premature. We had agreed to wait until things flushed out rather than sling mud at each other. The market place will decide the winner not you or me.